Active Pharmaceutical Ingredient (API)
Voglibose
Alpha-Glucosidase Inhibitor
An alpha-glucosidase inhibitor used to manage postprandial (after-meal) hyperglycemia in Type 2 Diabetes. It works by delaying the digestion and absorption of carbohydrates in the small intestine, leading to a flatter, lower rise in blood glucose levels. Its mechanism means its primary side effects are gastrointestinal (flatulence, abdominal discomfort).
Technical Profile
- Reference Code
- VOG045
- CAS Number
- 83480-29-9
- Molecular Weight
- 235.28 g/mol
- Chemical Class
- N/A
- Molecular Formula
- C10H21NO5
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Voglibose as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| No verified brands found for this salt. | ||||